Filing metadata

Accession number
0001127602-23-002111
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jan 24, 2023
Reporting period
Jan 20, 2023
Description
Insider transaction

Explore SEC Filings Hub